|
|
Blood, 1 September 2005, Vol. 106, No. 5, pp. 1604-1611.
Prepublished online as a Blood First Edition Paper on March 1, 2005; DOI 10.1182/blood-2004-03-1095.
Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Tissue-factorbearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation
Ian del Conde,
Corie N. Shrimpton,
Perumal Thiagarajan, and
José A. López
From the Thrombosis Research Section, Department of Medicine, Baylor College of Medicine, Houston, TX.
Tissue factor (TF) circulates in plasma, largely on monocyte/macrophage-derived microvesicles that can bind activated platelets through a mechanism involving P-selectin glycoprotein ligand-1 (PSGL-1) on the microvesicles and P-selectin on the platelets. We found these microvesicles to be selectively enriched in both TF and PSGL-1, and deficient in CD45, suggesting that they arise from distinct membrane microdomains. We investigated the possibility that microvesicles arise from cholesterol-rich lipid rafts and found that both TF and PSGL-1, but not CD45, localize to lipid rafts in blood monocytes and in the monocytic cell line THP-1. Consistent with a raft origin of TF-bearing microvesicles, their shedding was significantly reduced with depletion of membrane cholesterol. We also evaluated the interaction between TF-bearing microvesicles and platelets. Microvesicles bound only activated platelets, and required PSGL-1 to do so. The microvesicles not only bound the activated platelets, they fused with them, transferring both proteins and lipid to the platelet membrane. Fusion was blocked by either annexin V or an antibody to PSGL-1 and had an important functional consequence: increasing the proteolytic activity of the TF-VIIa complex. These findings suggest a mechanism by which all of the membrane-bound reactions of the coagulation system can be localized to the surface of activated platelets.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Orfeo, K. E. Brummel-Ziedins, M. Gissel, S. Butenas, and K. G. Mann
The Nature of the Stable Blood Clot Procoagulant Activities
J. Biol. Chem.,
April 11, 2008;
283(15):
9776 - 9786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. M. Okorie, W. S. Denney, M. S. Chatterjee, K. B. Neeves, and S. L. Diamond
Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow
Blood,
April 1, 2008;
111(7):
3507 - 3513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Schouten, W. J. Wiersinga, M. Levi, and T. van der Poll
Inflammation, endothelium, and coagulation in sepsis
J. Leukoc. Biol.,
March 1, 2008;
83(3):
536 - 545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Bakouboula, O. Morel, A. Faure, F. Zobairi, L. Jesel, A. Trinh, M. Zupan, M. Canuet, L. Grunebaum, A. Brunette, et al.
Procoagulant Membrane Microparticles Correlate with the Severity of Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med.,
March 1, 2008;
177(5):
536 - 543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. R. Pendurthi, S. Ghosh, S. K. Mandal, and L. V. M. Rao
Tissue factor activation: is disulfide bond switching a regulatory mechanism?
Blood,
December 1, 2007;
110(12):
3900 - 3908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Canault, A. S. Leroyer, F. Peiretti, G. Leseche, A. Tedgui, B. Bonardo, M.-C. Alessi, C. M. Boulanger, and G. Nalbone
Microparticles of Human Atherosclerotic Plaques Enhance the Shedding of the Tumor Necrosis Factor-{alpha} Converting Enzyme/ADAM17 Substrates, Tumor Necrosis Factor and Tumor Necrosis Factor Receptor-1
Am. J. Pathol.,
November 1, 2007;
171(5):
1713 - 1723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Lwaleed, A. J. Cooper, D. Voegeli, and K. Getliffe
Tissue Factor: A Critical Role in Inflammation and Cancer
Biol Res Nurs,
October 1, 2007;
9(2):
97 - 107.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Versteeg and W. Ruf
Tissue Factor Coagulant Function Is Enhanced by Protein-disulfide Isomerase Independent of Oxidoreductase Activity
J. Biol. Chem.,
August 31, 2007;
282(35):
25416 - 25424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Mackman, R. E. Tilley, and N. S. Key
Role of the Extrinsic Pathway of Blood Coagulation in Hemostasis and Thrombosis
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2007;
27(8):
1687 - 1693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Panes, V. Matus, C. G. Saez, T. Quiroga, J. Pereira, and D. Mezzano
Human platelets synthesize and express functional tissue factor
Blood,
June 15, 2007;
109(12):
5242 - 5250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. CEDERHOLM and J. FROSTEGARD
Annexin A5 as a Novel Player in Prevention of Atherothrombosis in SLE and in the General Population
Ann. N.Y. Acad. Sci.,
June 1, 2007;
1108(1):
96 - 103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Boden, V. Vaidyula, C. Homko, M. Mozzoli, and A. K. Rao
Differential effects of somatostatin on circulating tissue factor procoagulant activity and protein
Am J Physiol Endocrinol Metab,
May 1, 2007;
292(5):
E1333 - E1339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. Shaw, V. S. Pureza, S. G. Sligar, and J. H. Morrissey
The Local Phospholipid Environment Modulates the Activation of Blood Clotting
J. Biol. Chem.,
March 2, 2007;
282(9):
6556 - 6563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Maroney, S. L. Haberichter, P. Friese, M. L. Collins, J. P. Ferrel, G. L. Dale, and A. E. Mast
Active tissue factor pathway inhibitor is expressed on the surface of coated platelets
Blood,
March 1, 2007;
109(5):
1931 - 1937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-L. Liu, M. P. Reilly, P. Casasanto, S. E. McKenzie, and K. J. Williams
Cholesterol Enrichment of Human Monocyte/Macrophages Induces Surface Exposure of Phosphatidylserine and the Release of Biologically-Active Tissue Factor-Positive Microvesicles
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2007;
27(2):
430 - 435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Morel, F. Toti, B. Hugel, B. Bakouboula, L. Camoin-Jau, F. Dignat-George, and J.-M. Freyssinet
Procoagulant Microparticles: Disrupting the Vascular Homeostasis Equation?
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2006;
26(12):
2594 - 2604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Schwertz, N. D. Tolley, J. M. Foulks, M. M. Denis, B. W. Risenmay, M. Buerke, R. E. Tilley, M. T. Rondina, E. M. Harris, L. W. Kraiss, et al.
Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity of human platelets
J. Exp. Med.,
October 30, 2006;
203(11):
2433 - 2440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. V. Mitsios, M. P. Vini, D. Stengel, E. Ninio, and A. D. Tselepis
Human Platelets Secrete the Plasma Type of Platelet-Activating Factor Acetylhydrolase Primarily Associated With Microparticles
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2006;
26(8):
1907 - 1913.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Reininger, H. F. G. Heijnen, H. Schumann, H. M. Specht, W. Schramm, and Z. M. Ruggeri
Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress
Blood,
May 1, 2006;
107(9):
3537 - 3545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Bach
Tissue Factor Encryption
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2006;
26(3):
456 - 461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Guessous, M. Marcinkiewicz, R. Polanowska-Grabowska, S. Kongkhum, D. Heatherly, T. Obrig, and A. R. L. Gear
Shiga Toxin 2 and Lipopolysaccharide Induce Human Microvascular Endothelial Cells To Release Chemokines and Factors That Stimulate Platelet Function
Infect. Immun.,
December 1, 2005;
73(12):
8306 - 8316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. L. Gross, B. C. Furie, G. Merrill-Skoloff, J. Chou, and B. Furie
Leukocyte-versus microparticle-mediated tissue factor transfer during arteriolar thrombus development
J. Leukoc. Biol.,
December 1, 2005;
78(6):
1318 - 1326.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |